Integrated Investment Consultants LLC Holds Stake in Medtronic PLC (MDT)

Integrated Investment Consultants LLC continued to hold its position in Medtronic PLC (NYSE:MDT) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,122 shares of the medical technology company’s stock at the end of the 2nd quarter. Integrated Investment Consultants LLC’s holdings in Medtronic PLC were worth $100,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Medtronic PLC by 4.5% during the first quarter. Vanguard Group Inc. now owns 102,321,656 shares of the medical technology company’s stock valued at $8,243,034,000 after buying an additional 4,412,536 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Medtronic PLC by 2,513.4% during the first quarter. BlackRock Inc. now owns 87,035,376 shares of the medical technology company’s stock valued at $7,011,571,000 after buying an additional 83,705,052 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Medtronic PLC by 3.0% during the first quarter. Massachusetts Financial Services Co. MA now owns 58,646,070 shares of the medical technology company’s stock valued at $4,724,526,000 after buying an additional 1,729,715 shares during the last quarter. Lazard Asset Management LLC grew its holdings in shares of Medtronic PLC by 1,061.4% during the first quarter. Lazard Asset Management LLC now owns 13,678,772 shares of the medical technology company’s stock valued at $1,101,960,000 after buying an additional 12,500,992 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Medtronic PLC by 7.3% during the first quarter. Geode Capital Management LLC now owns 13,308,812 shares of the medical technology company’s stock valued at $1,070,622,000 after buying an additional 906,581 shares during the last quarter. Hedge funds and other institutional investors own 80.62% of the company’s stock.

Medtronic PLC (MDT) traded down 0.04% on Thursday, reaching $80.13. 2,325,364 shares of the company’s stock traded hands. Medtronic PLC has a 12-month low of $69.35 and a 12-month high of $89.72. The stock has a market cap of $108.54 billion, a price-to-earnings ratio of 26.97 and a beta of 1.03. The stock has a 50 day moving average price of $82.04 and a 200 day moving average price of $83.67.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.08 by $0.04. The business had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.03 EPS. Analysts forecast that Medtronic PLC will post $4.77 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date of this dividend is Thursday, September 28th. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.

A number of research firms have recently commented on MDT. Zacks Investment Research cut shares of Medtronic PLC from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. BidaskClub cut shares of Medtronic PLC from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. UBS AG reiterated an “overweight” rating on shares of Medtronic PLC in a report on Thursday, August 24th. Jefferies Group LLC cut their price target on shares of Medtronic PLC from $103.00 to $96.00 and set a “buy” rating on the stock in a report on Wednesday, August 23rd. Finally, Barclays PLC cut their price target on shares of Medtronic PLC from $94.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, August 23rd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $88.78.

TRADEMARK VIOLATION WARNING: This piece was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/2908035/integrated-investment-consultants-llc-holds-stake-in-medtronic-plc-mdt.html.

In related news, CEO Omar Ishrak sold 140,407 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the sale, the chief executive officer now directly owns 668,503 shares of the company’s stock, valued at $54,569,899.89. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the stock in a transaction on Monday, July 17th. The stock was sold at an average price of $88.57, for a total transaction of $1,062,840.00. The disclosure for this sale can be found here. Corporate insiders own 0.31% of the company’s stock.

Medtronic PLC Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.